GLP-1 medications in Phenotype C phenotypes reduce disease endpoints, but this is not the same thing as saying everyone should be on them, and it's not the same thing as saying they're anti-aging; it means in specific phenotypes, they reduce disease momentum.
normativepending
Speaker
Dr. Amin DadgarEvidence Quote
“That's not the same thing as saying everyone should be on them. And it's not the same thing as saying they're anti-aging. It means in specific phenotypes, they reduce disease momentum.”
Created: 8/12/2026, 6:40:36 PM
Your notes
Loading notes...